Publications by authors named "Anneleen Lintermans"

Claim this Profile
T
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Patrick Neven, Lynn Jongen, Anneleen Lintermans, Kathleen Van Asten, Chantal Blomme

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.
N Lynn Henry, Kelly Speth, Anneleen Lintermans, Kelley M Kidwell, Rachel Carlson

Clin Breast Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of aromatase inhibitor therapy in breast cancer.
Anneleen Lintermans, Patrick Neven

Expert Opin Drug Saf· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.
Kathleen Van Asten, An Poppe, Kevin Punie, Lynn Jongen, Anneleen Lintermans

Curr Treat Options Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Anneleen Lintermans, Dirk Vanderschueren, Johan Verhaeghe, Kathleen Van Asten, Ivo Jans

Eur J Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Gilbert Donders, Patrick Neven, Maximilian Moegele, Anneleen Lintermans, Gert Bellen

Breast Cancer Res Treat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase inhibitors in the breast cancer clinic: focus on exemestane.
Kathleen Van Asten, Patrick Neven, Anneleen Lintermans, Hans Wildiers, Robert Paridaens

Endocr Relat Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitive routine liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone without derivatization.
Steven Pauwels, Leen Antonio, Ivo Jans, Anneleen Lintermans, Patrick Neven

Anal Bioanal Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitors.
Steven Pauwels, Anneleen Lintermans, Patrick Neven, Johan Verhaeghe, Ivo Jans

J Clin Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anastrozole and fulvestrant in metastatic breast cancer.
Anneleen Lintermans, Joke Vanderhaegen, Patrick Neven

N Engl J Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of arthralgia with estrogen deprivation.
Anneleen Lintermans, Patrick Neven

Steroids· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety evaluation of exemestane.
Anneleen Lintermans, Patrick Neven, Robert Paridaens

Expert Opin Drug Saf· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis